Detalhe da pesquisa
1.
An inferior vena cava-priority approach in laparoscopic isolated hepatic caudate lobectomy.
Langenbecks Arch Surg
; 409(1): 106, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38556526
2.
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma.
Br J Cancer
; 128(5): 907-917, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36526676
3.
Development of preoperative prognostic models including radiological features for survival of singular nodular HCC patients.
Hepatobiliary Pancreat Dis Int
; 22(1): 72-80, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428596
4.
HBV/Pregenomic RNA Increases the Stemness and Promotes the Development of HBV-Related HCC Through Reciprocal Regulation With Insulin-Like Growth Factor 2 mRNA-Binding Protein 3.
Hepatology
; 74(3): 1480-1495, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33825218
5.
Circulating Tumor Cells Expressing Krüppel-Like Factor 8 and Vimentin as Predictors of Poor Prognosis in Pancreatic Cancer Patients.
Cancer Control
; 28: 10732748211027163, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34378430
6.
Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis.
Mol Cell
; 49(6): 1083-96, 2013 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23395002
7.
A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma.
J Hepatol
; 70(5): 904-917, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30654066
8.
Tropomodulin 3 modulates EGFR-PI3K-AKT signaling to drive hepatocellular carcinoma metastasis.
Mol Carcinog
; 58(10): 1897-1907, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31313392
9.
Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma.
Hepatology
; 63(3): 850-63, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26663434
10.
Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1.
Hepatology
; 63(2): 499-511, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25964079
11.
Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma.
Mol Cancer
; 14: 170, 2015 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26376879
12.
Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial.
Ann Surg
; 261(1): 56-66, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25072444
13.
Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling.
Mol Carcinog
; 54(12): 1584-95, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25307746
14.
Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2.
Hepatology
; 60(4): 1278-90, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043274
15.
Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer.
Mol Pharm
; 12(2): 644-52, 2015 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25495890
16.
Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
Hepatology
; 57(5): 1882-92, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23239537
17.
Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma.
Carcinogenesis
; 34(3): 577-86, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23222811
18.
Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy.
Hepatology
; 56(6): 2231-41, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22706893
19.
Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study.
Front Immunol
; 14: 1198562, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37483609
20.
Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation.
Exp Mol Med
; 55(11): 2390-2401, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37907737